about
Development of manganese-based nanoparticles as contrast probes for magnetic resonance imagingNanotheranostics for personalized medicineTumor vasculature targeted photodynamic therapy for enhanced delivery of nanoparticles.Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma.Integrin Targeted Imaging and Therapy.Targeted nanoprobes reveal early time point kinetics in vivo by time-resolved MRISurface-engineered magnetic nanoparticle platforms for cancer imaging and therapyNew Methods for Labeling RGD Peptides with Bromine-76.Strategies for Target-Specific Contrast Agents for Magnetic Resonance ImagingcRGD peptide-conjugated icosahedral closo-B12(2-) core carrying multiple Gd3+-DOTA chelates for α(v)β3 integrin-targeted tumor imaging (MRI).A concise review of magnetic resonance molecular imaging of tumor angiogenesis by targeting integrin αvβ3 with magnetic probesFerritin nanocages to encapsulate and deliver photosensitizers for efficient photodynamic therapy against cancer.Polymeric materials for theranostic applications.MRI-visible liposome nanovehicles for potential tumor-targeted delivery of multimodal therapies.Theranostic cRGD-BioShuttle Constructs Containing Temozolomide- and Cy7 For NIR-Imaging and Therapy.Tracking and Quantification of Magnetically Labeled Stem Cells using Magnetic Resonance Imaging.SPPS resins impact the PNA-syntheses' improvement.Targeted Dual pH-Sensitive Lipid ECO/siRNA Self-Assembly Nanoparticles Facilitate In Vivo Cytosolic sieIF4E Delivery and Overcome Paclitaxel Resistance in Breast Cancer Therapy.RGD-Modified Albumin Nanoconjugates for Targeted Delivery of a Porphyrin Photosensitizer.Gelatinase activity imaged by activatable cell-penetrating peptides in cell-based and in vivo models of stroke.
P2860
Q22064299-E9003CC4-B06E-4887-81EC-C57581CA3C11Q26851449-E6CA3760-438F-42CA-ADD7-945031354045Q33824812-4CB9273E-CCFF-4B3B-8CDA-AFD7C912A06CQ34287136-84439D8C-FF96-4125-AD45-556933FD41F1Q34786949-27E4A650-C383-4714-91CF-F47947C71870Q34974123-8251DD4D-807E-4F08-988A-580708ABE3D0Q35194685-115FD4A0-F488-43F9-AD6E-C8369CB7F5C1Q35224462-6B0EC968-7230-47CD-B95C-33C1C9F2E77BQ36517070-01CA955C-D352-4FBF-A42A-0581E81C8264Q36671358-F25A465D-7521-4C4A-B222-F46C225E9659Q36694514-525F3DD3-2CF4-45EC-B9AD-E11E0DA4C921Q37284363-FED88AE2-8A74-4B1A-AAF6-FE77F22CD206Q38114360-EA36016D-73D5-490D-A136-2562C709A596Q38869805-471D4087-EF2E-4A2C-AE5D-20F6EC9321FBQ40066911-4E9322F0-24CA-4154-AF20-04617C272263Q41121610-39BEC60F-81DC-464F-9684-6D01316B0203Q41782961-34965D0E-A68F-432A-90A3-CC7E5C85FC59Q42754623-C078035F-652C-4B57-BA98-C3C379CFA251Q42799162-CE99020B-35CE-4108-8EEC-FE76C2900D88Q46110252-7C4166A8-09CD-4913-9F16-DC1ABFE19D2F
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Integrin Targeted MR Imaging.
@ast
Integrin Targeted MR Imaging.
@en
type
label
Integrin Targeted MR Imaging.
@ast
Integrin Targeted MR Imaging.
@en
prefLabel
Integrin Targeted MR Imaging.
@ast
Integrin Targeted MR Imaging.
@en
P2860
P356
P1433
P1476
Integrin Targeted MR Imaging.
@en
P2093
Mingqian Tan
Zheng-Rong Lu
P2860
P304
P356
10.7150/THNO/V01P0083
P577
2011-01-19T00:00:00Z